Solowin Holdings Ordinary Share
NASDAQ:AXGFinancial - Capital Markets
-$0.02 today
- Market cap
- $56.55M
- Beta
- -0.23
- P/E (TTM)
- -265.7
- EPS (TTM)
- -$0.01
Volume 0.90M
Average 0.24M
AXG Deferred Income Tax
The difference between tax expense recognized and tax actually paid in cash during the period.
Solowin Holdings Ordinary ShareNASDAQ: AXG
Deferred Income Tax · Q2 FY2026 · quarter ended Sep 2025
Deferred income tax outflow grows to $0
Q2 FY2026 deferred income tax was $0, compared with $0 a year earlier.
Context
- Deferred income tax amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Deferred income tax increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Deferred Income Tax history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Deferred Income Tax | YoY change |
|---|---|---|---|
| FY2025 | 2025-03-31 | 0 | — |
| FY2024 | 2024-03-31 | 0 | — |
| FY2023 | 2023-03-31 | 0 | — |
| FY2022 | 2022-03-31 | 0 | — |
| FY2021 | 2021-03-31 | 0 | — |
Deferred Income Tax vs competitors
How AXG compares with its peers on the latest reported figures
- AXG's FY2025 deferred income tax of $0 is the 2nd largest of the 3 companies compared; the peer median is $101.5M.
- Deferred income tax amounts to 0.0% of revenue for AXG, versus a peer median of 1.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $203M | +2130.0% | +52.5% | 2.1% | |
AXGSolowin Holdings Ordinary Share | FY2025 | $0 | — | — | 0.0% |
BCICBCP Investment Corporation | LTM Mar 2026 | $0 | — | — | 0.0% |
| Peer median (excluding AXG) | $101.5M | +2130.0% | +52.5% | 1.1% | |
Competitors are the stored peer set for AXG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Mar 2021 | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 |
|---|---|---|---|---|---|
| Net Income | (83.2K) | (125.76K) | 172.09K | (582.27K) | (1.1M) |
| Depreciation & Amortization | 1.55K | 2.44K | 2.3K | 3.83K | 12.7K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 1.5M | (626.5K) | (233.2K) | (764.14K) | 533.03K |
| Accounts Receivables | (14.19K) | (24.28K) | (146.83K) | (308.52K) | 440.13K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 1.52M | (602.48K) | (120.04K) | (157.84K) | (11.42K) |
| Other Working Capital | (3.22K) | 257 | 33.68K | (297.78K) | 104.32K |
| Other Non-Cash Items | 7.87K | 12.72K | 2.3K | 625.98K | 414.21K |
| Operating Cash Flow | 1.42M | (737.11K) | (56.51K) | (716.6K) | (135.63K) |
| Capital Expenditures | (4.77K) | (2.18K) | (1.02K) | (18.02K) | (11.29K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | (32.85K) | (84.43K) |
| Sales of Investments | 0 | 0 | 0 | 0 | 6.42K |
| Other Investing Activities | 50.05K | 16.83K | 29.72K | (122.44K) | 129.6K |
| Investing Cash Flow | 45.27K | 14.64K | 28.7K | (175.86K) | 36.83K |
| Debt Repayment | (1.68K) | (8.22K) | 255 | 0 | 0 |
| Common Stock Issued | 0 | 0 | (43.76K) | 850.66K | 128.32K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (4.51K) | 195.77K | 0 | 8.18K | 176.57K |
| Financing Cash Flow | (6.19K) | 187.55K | (43.5K) | 858.84K | 304.88K |
| Effect of Forex Changes | (1.39M) | 589.95K | 191.78K | 61.82K | 13.79K |
| Net Change in Cash | 69.72K | 55.04K | 120.47K | 28.21K | 219.87K |
| Free Cash Flow | 1.42M | (739.29K) | (57.53K) | (734.62K) | (146.92K) |
Solowin Holdings Ordinary Share
NASDAQ:AXG
Intrinsic Alpha fair value
Locked
Current Price
$1.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.